Vivos Sistema de Cirurxía Oftalmolóxica de Olcayto Guelec and David Geuder

O deseño Vivos Sistema de Cirurxía Oftalmolóxica de Olcayto Guelec and David Geuder é un estimado gañador do moi prestixioso 2026 A' Design Award de Ouro na Categoría de Competición Deseño de Dispositivos e Equipos Médicos.

OuroProduto Médico· 2026

Vivos Sistema de Cirurxía Oftalmolóxica

de Olcayto Guelec and David Geuder

Cliente: Geuder AG

Gañador do A' Design Award de Ouro na Categoría Produto Médico

56,783

Gañador de Premio Verificado

Verificar o Estado do Premio para #182492

Ver en A' Design Award Nota de prensa Distintivo do premio

Cores

O Deseño

Sobre Vivos Sistema de Cirurxía Oftalmolóxica

Vivos redefine a estación de traballo cirúrxica como unha plataforma que evoluciona xunto coa ambición clínica. Tres configuracións, Core, Nova e Nova+, amplían a capacidade sen necesidade de substituír o sistema, a única arquitectura de actualización deste tipo na cirurxía oftalmolóxica. Unha interface única, validada cun 91,7 por cento de satisfacción no primeiro uso sen formación previa, reflicte un deseño construído arredor do cirurxián en lugar do procedemento. As conexións iluminadas dos instrumentos, os materiais refinados e os detalles contidos dótanlle ao dispositivo unha presenza tranquila e segura, libre do ruído visual típico da categoría.

O Recoñecemento

Sobre o A' Design Award de Ouro

Vivos Sistema de Cirurxía Oftalmolóxica gañou o A' Design Award de Ouro, un recoñecemento inmensamente prestixioso outorgado a deseños de primeira clase, marabillosos e sobresaíntes. Os gañadores Ouro son creacións sumamente innovadoras, visionarias e glamurosamente deslumbrantes que reflicten o xenio, a sabedoría e a destreza dos seus deseñadores. Espérase que Vivos Sistema de Cirurxía Oftalmolóxica sexa unha invención moi eloxiada, pioneira e monumental que ofrece un valor sen precedentes. Este deseño gañador do A' Design Award de Ouro é un proxecto espectacular e respectado que beneficia moito a arte, a ciencia, o deseño e a tecnoloxía e fai avanzar os seus límites. Vivos Sistema de Cirurxía Oftalmolóxica crea intensos sentimentos de desexo, esperta a paixón, anima a creatividade e fascina.

Detrás do deseño

Kit de prensa

Créditos, membros do equipo e detalles técnicos proporcionados polo deseñador.

Propiedades Únicas: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensións e Embalaxe: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Etiquetas: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Tecnoloxía de Produción: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Reto de Deseño: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Investigación: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiración: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Duración do Proxecto: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Fluxo de Operacións: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Membros do Equipo: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Créditos das Imaxes: Photography Geuder AG, 2026